
UHS Stock Forecast & Price Target
UHS Analyst Ratings
Bulls say
Universal Health Services has demonstrated a strong financial performance, with its acute care segment's same-store adjusted EBITDA margin expanding by 190 basis points to 15.8%. The behavioral health segment has also shown robust growth, with same-store revenue increasing by 9.3%, while overall patient volumes and revenue per adjusted admission reflect positive trends. The company's strategic initiatives pending CMS approval could yield an estimated benefit of $75-80 million, further bolstering its favorable outlook for sustained revenue growth and margin improvement in 2026.
Bears say
Universal Health Services is facing a negative outlook primarily due to projected earnings that are approximately 5% below earlier estimates for fiscal year 2026, resulting from anticipated volume and margin challenges. The company’s behavioral volumes are expected to trend at only 2% for 2026, following a downward adjustment in its long-term growth outlook, which could significantly impact EBITDA as the contribution from its DPP segment is projected to decline starting in 2028. Additional risks include high market concentration in Las Vegas, potential regulatory changes, and tightening labor supply that could further weaken productivity and margins in urban areas.
This aggregate rating is based on analysts' research of Universal Health Services and is not a guaranteed prediction by Public.com or investment advice.
UHS Analyst Forecast & Price Prediction
Start investing in UHS
Order type
Buy in
Order amount
Est. shares
0 shares